abrdn Life Sciences Investors (HQL): auditor change — Tekla Life Sciences Investors auditor Deloitte resigns; KPMG appointed as new auditor

abrdn Life Sciences Investors

Deloitte resigned on Sept 6, 2023 due to anticipated independence issue from pending transaction between Tekla Capital Management and abrdn Inc.
Audit Committee approved resignation on Sept 7; no disagreements or reportable events in prior two fiscal years.
KPMG engaged as independent auditor for fiscal year ending Sept 30, 2023, effective Sept 7, 2023.
No prior consultations with KPMG on accounting principles, audit opinions, or disagreements.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Deloitte & Touche LLP resigned as auditor of abrdn Life Sciences Investors.

Action: resignation
Auditor: Deloitte & Touche LLP
Successor: KPMG LLP

Exact text from the filing

On September 6, 2023, Deloitte & Touche LLP ("D&T"), the independent registered public accounting firm for the Tekla Life Sciences Investors (the "Fund"), resigned due to an anticipated independence issue

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

abrdn Life Sciences Investors engaged KPMG LLP as its auditor.

Action: engagement
Auditor: KPMG LLP

Exact text from the filing

On September 7, 2023, upon the recommendation of the Audit Committee of the Board, the Board approved the engagement of KPMG LLP ("KPMG") as the independent registered public accounting firm for the Fund for the fiscal year ending September 30, 2023

View on SEC.gov

Browse all auditor changes →

abrdn Life Sciences Investors filing history →

Source: SEC EDGAR

accession 0001104659-23-100077

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.